Globus Medical, Inc.
MX ˙ BMV ˙ US3795772082
SecurityMX:GMED / Globus Medical, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership600,456 shares
Latest Disclosed Value $ 51,735,300
Fmr Llc reports 1,121.33% increase in ownership of GMED / Globus Medical, Inc.

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 600,456 shares of Globus Medical, Inc. (MX:GMED) valued at $51,735,300 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 49,164 shares of Globus Medical, Inc.. This represents a change in shares of 1,121.33% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F GLOBUS MED CL A 379577208 600,456 551,292 1,121.33 51,735 1,105.38 0.0005
2026-02-17 2025-12-31 13F GLOBUS MED CL A 379577208 49,164 994 2.06 4,293 55.62 0.0002
2025-11-13 2025-09-30 13F GLOBUS MED CL A 379577208 48,170 -712,212 -93.67 2,759 -93.85 0.0001
2025-08-14 2025-06-30 13F GLOBUS MED CL A 379577208 760,382 486,366 177.50 44,878 123.75 0.0025
2025-05-12 2025-03-31 13F GLOBUS MED CL A 379577208 274,016 -153,268 -35.87 20,058 -43.25 0.0013
2025-02-13 2024-12-31 13F GLOBUS MED CL A 379577208 427,284 388,561 1,003.44 35,341 1,175.81 0.0021
2024-11-13 2024-09-30 13F GLOBUS MED CL A 379577208 38,723 29,890 338.39 2,770 358.61 0.0002
2024-08-13 2024-06-30 13F GLOBUS MED CL A 379577208 8,833 -37,294 -80.85 605 -75.59 0.0000
2024-05-13 2024-03-31 13F GLOBUS MED CL A 379577208 46,127 2,420 5.54 2,474 6.23 0.0002
2024-02-13 2023-12-31 13F GLOBUS MED CL A 379577208 43,707 4,436 11.30 2,329 19.50 0.0002
2023-11-13 2023-09-30 13F GLOBUS MED CL A 379577208 39,271 31,936 435.39 1,950 347.02 0.0002
2023-08-11 2023-06-30 13F GLOBUS MED CL A 379577208 7,335 2,422 49.30 437 56.83 0.0000
2023-08-11 2023-03-31 13F/A-1 GLOBUS MED CL A 379577208 4,913 -490,046 -99.01 278 -99.24 0.0000
2023-05-11 2023-03-31 13F GLOBUS MED CL A 379577208 4,913 -490,046 278 0.0000
2023-02-13 2022-12-31 13F GLOBUS MED CL A 379577208 494,959 -13,372 -2.63 36,761 21.40 0.0037
2022-11-10 2022-09-30 13F GLOBUS MED CL A 379577208 508,331 10,825 2.18 30,281 8.42 0.0032
2022-08-12 2022-06-30 13F GLOBUS MED CL A 379577208 497,506 -388,562 -43.85 27,929 -57.28 0.0028
2022-05-13 2022-03-31 13F GLOBUS MED CL A 379577208 886,068 34,020 3.99 65,374 6.27 0.0052
2022-02-14 2021-12-31 13F GLOBUS MED CL A 379577208 852,048 -87,274 -9.29 61,518 -14.52 0.0045
2022-02-14 2021-09-30 13F/A-1 GLOBUS MED CL A 379577208 939,322 3,763 0.40 71,971 -0.77 0.0057
2021-11-15 2021-09-30 13F GLOBUS MED CL A 379577208 939,322 3,763 71,971 0.0011
2021-08-13 2021-06-30 13F GLOBUS MED CL A 379577208 935,559 130,980 16.28 72,533 46.18 0.0057
2021-05-14 2021-03-31 13F GLOBUS MED CL A 379577208 804,579 203,199 33.79 49,619 26.51 0.0042
2021-02-08 2020-12-31 13F GLOBUS MED CL A 379577208 601,380 600,323 56,794.99 39,222 75,326.92 0.0035
2020-11-13 2020-09-30 13F GLOBUS MED CL A 379577208 1,057 184 21.08 52 23.81 0.0000
2020-08-24 2020-06-30 13F/A-1 GLOBUS MED CL A 379577208 873 -294 -25.19 42 -16.00 0.0000
2020-08-13 2020-06-30 13F GLOBUS MED CL A 379577208 873 -294 42 1.0318
2020-05-14 2020-03-31 13F GLOBUS MED CL A 379577208 1,167 -1,390 -54.36 50 -66.89 0.0000
2020-02-07 2019-12-31 13F GLOBUS MED CL A 379577208 2,557 1,268 98.37 151 128.79 0.0000
2019-11-13 2019-09-30 13F GLOBUS MED CL A 379577208 1,289 143 12.48 66 37.50 0.0000
2019-08-13 2019-06-30 13F GLOBUS MED CL A 379577208 1,146 -1,155 -50.20 48 -57.52 0.0000
2019-05-13 2019-03-31 13F GLOBUS MED CL A 379577208 2,301 -644,957 -99.64 113 -99.60 0.0000
2019-02-13 2018-12-31 13F GLOBUS MED CL A 379577208 647,258 -289,195 -30.88 28,013 -47.30 0.0038
2018-11-09 2018-09-30 13F GLOBUS MED CL A 379577208 936,453 8,871 0.96 53,154 13.56 0.0060
2018-08-10 2018-06-30 13F GLOBUS MED CL A 379577208 927,582 927,582 46,806 0.0055
2017-11-13 2017-09-30 13F GLOBUS MED CL A 379577208 0 -500,086 -100.00 0 -100.00
2017-08-29 2017-06-30 13F/A-1 GLOBUS MED CL A 379577208 500,086 86 0.02 16,578 11.94 0.0021
2017-08-11 2017-06-30 13F GLOBUS MED CL A 379577208 500,086 86 16,578
2017-05-11 2017-03-31 13F GLOBUS MED CL A 379577208 500,000 19,986 4.16 14,810 24.36 0.0019
2017-02-10 2016-12-31 13F GLOBUS MED CL A 379577208 480,014 480,014 11,909 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.